• 1
    Mackay IM, Arden KE, Nitsche A. Real-time PCR in virology. Nucleic Acids Res 2002; 30: 12921305.
  • 2
    Niesters HGM. Quantitation of viral load using real-time amplification techniques. Methods 2001; 25: 419429.
  • 3
    Quint WGV, Heijtink RA, Schirm J, Gerlich WH, Niesters HGM. Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol 1995; 33: 225228.
  • 4
    Schuurman R, Descamps D, Weverling GJ et al. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996; 34: 30163022.
  • 5
    Zaaijer HL, Cuypers HT, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722724.
  • 6
    Damen M, Cuypers HT, Zaaijer HL et al. International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods 1996; 58: 175185.
  • 7
    Zaaijer HL, Ter Borg F, Cuypers HT, Hermus MC, Lelie PN. Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol 1994; 32: 20882091.
  • 8
    Valentine-Thon E, Van Loon AM, Schirm J, Reid J, Klapper PE, Cleator GM. European Proficiency Testing Program for molecular detection and quantitation of hepatitis B virus DNA. J Clin Microbiol 2001; 39: 44074412.
  • 9
    Van Vliet KE, Muir P, Echevarria JM, Klapper PE, Cleator GM, Van Loon AM. Multicenter proficiency testing of nucleic acid amplification methods for the detection of enteroviruses. J Clin Microbiol 2001; 39: 33903392.
  • 10
    Saldanha J, Lelie N, Heath A. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO Collaborative Study Group. Vox Sang 1999; 76: 149158.
  • 11
    Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001; 80: 6371.
  • 12
    Van Esser JW, Niesters HGM, Van Der Holt B et al. Prevention of Epstein–Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 2002; 99: 43644369.
  • 13
    Van Esser JW, Van Der Holt B, Meijer E et al. Epstein–Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 2001; 98: 972978.
  • 14
    Van Esser JW, Niesters HG, Thijsen SF et al. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein–Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol 2001; 113: 814821.
  • 15
    Niesters HG, Van Esser J, Fries E, Wolthers KC, Cornelissen JJ, Osterhaus AD. Development of a real-time quantitative assay for detection of Epstein–Barr virus. J Clin Microbiol 2000; 38: 712715.
  • 16
    Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355: 20322036.
  • 17
    Emery VC, Griffiths PD. Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy. Proc Natl Acad Sci USA 2000; 97: 80398044.
  • 18
    Humar AD, Kumar D, Boivin G, Caliendo AM. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis 2002; 186: 829833.
  • 19
    EASL. International Consensus Conference on hepatitis C. Consensus statement. J Hepatol 1999; 31(suppl 1): 38.
  • 20
    Sugauchi F, Orito E, Ichida T et al. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol 2002; 76: 59855992.
  • 21
    Schuurman R, Demeter L, Reichelderfer P, Tijnagel J, De Groot T, Boucher C. Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase. J Clin Microbiol 1999; 37: 22912296.
  • 22
    Stuyver L, Wyseur A, Rombout A et al. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob Agents Chemother 1997; 41: 284291.
  • 23
    Stuyver L, Van Geyt C, De Gendt S et al. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol 2000; 38: 702707.
  • 24
    Pas SD, De Man RA, Fries E, Osterhaus AD, Niesters HG. The dynamics of mutations in the YMDD motif of the hepatitis B virus polymerase gene during and after lamivudine treatment as determined by reverse hybridisation. J Clin Virol 2002; 25: 6371.
  • 25
    Allen MI, Gauthier J, Deslauriers M et al. Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine. J Clin Microbiol 1999; 37: 33383347.
  • 26
    Niesters HG, De Man RA, Pas SD, Fries E, Osterhaus AD. Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy. J Med Microbiol 2002; 51: 695699.
  • 27
    Savolainen CS, Blomqvist S, Mulders MN, Hovi T. Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70. J Gen Virol 2002; 83: 333340.
  • 28
    Oberste MS, Maher K, Flemister MR, Marchetti G, Kilpatrick DR, Pallansch MA. Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol 2000; 38: 11701174.
  • 29
    Espy MJ, Uhl JR, Mitchell PS et al. Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol 2000; 38: 795799.
  • 30
    Van Den Hoogen BG, De Jong JC, Groen J et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7: 719724.